Answering the Call: Facing Addiction in America
Last week the Surgeon General, Dr. Vivek Murthy, released the groundbreaking, comprehensive report Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. The report comes at a critical juncture, with more than 27 million Americans misusing illicit and prescription drugs, and more than 66 million misusing alcohol. The Surgeon General details the […]
The Effect of Vaping Minimum Age Laws on Teen Smoking and Birth Outcomes
Public health advocates have been concerned about rising e-cigarette use (“vaping”) among teens. For the first time in 2014, teens reported being more likely to use e-cigarettes than regular cigarettes. New Jersey implemented the first law restricting the purchase of e-cigarettes or other electronic nicotine delivery systems (ENDS) in 2010; almost all states followed suit in the […]
A Computer Tool to Address Epidemic of Opioid Overdose Deaths
Pennsylvania Governor Tom Wolf on Thursday announced the launch of a new Prescription Drug Monitoring Program (PDMP) designed to log and analyze every prescription for opioids and other controlled substances dispensed anywhere in the state. The new web-based computer program is Pennsylvania’s latest tool in the battle to lower the body count of prescription drug […]
Zachary Meisel Wins $2.1 Million PCORI Funding Award
University of Pennsylvania Assistant Professor of Emergency Medicine and LDI Senior Fellow Zachary Meisel, MD, has received a $2.1 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). The award will fund a 36-month comparative effectiveness study of enhanced opioid risk communication strategies for pain management following acute care. Meisel’s research team includes LDI Senior Fellows Carolyn […]
Bridging Research and Policy: Q&A with Baltimore City Health Commissioner Leana Wen
In a recent panel discussion at Penn, Leana Wen, MD, MSc, Baltimore City Health Commissioner, spoke about the role of public health in Baltimore and how academic institutions can work with public health departments. I spoke with Dr. Wen before her panel about how policymakers use economic evidence, and how we can make evidence more useful to […]
State Medicaid Spending on Sovaldi: Wide Variation in Spending and Utilization in 2014
With a price tag of $1,000 per pill and $84,000 for a 12-week course of Sovaldi (sofosbuvir), Gilead Sciences prompted widespread concern about whether its new treatment for hepatitis C (HCV) would bankrupt public and private payers. These concerns were particularly significant for state Medicaid programs, which face both limited state budgets and high HCV […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.